MEDIPOST America

MEDIPOST provides services and develops products related to existing and uncontroversial sources—human umbilical cord blood and human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs). Stem cells from unrelated healthy donors have demonstrated the ability to regenerate and/or restore the function of various types of damaged tissues. This form of adult stem cell therapy, based on the "off-the-shelf" concept, has revolutionized medical treatments and ushered in a new era of mass-produced allogeneic stem cell drug products.